These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9294829

  • 1. Osteopontin in chronic puromycin aminonucleoside nephrosis.
    Magil AB, Pichler RH, Johnson RJ.
    J Am Soc Nephrol; 1997 Sep; 8(9):1383-90. PubMed ID: 9294829
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A.
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE, Ou SL, Velosa JA, Shah SV, Dousa TP.
    J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Feb; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats.
    Hartner A, Porst M, Gauer S, Pröls F, Veelken R, Hilgers KF.
    Am J Kidney Dis; 2001 Jul; 38(1):153-64. PubMed ID: 11431195
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis.
    Shu Y, Hoshi S, Tomari S, Watanabe T, Nagata M.
    Pathol Int; 2002 Mar; 52(3):214-23. PubMed ID: 11972865
    [Abstract] [Full Text] [Related]

  • 17. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB, Ricardo SD, Kelly DJ, Waanders F, van Goor H, Navis G.
    J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis.
    Rincon J, Romero M, Viera N, Pedreañez A, Mosquera J.
    Int J Exp Pathol; 2004 Feb; 85(1):25-33. PubMed ID: 15113391
    [Abstract] [Full Text] [Related]

  • 20. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
    Shiiki H, Sasaki Y, Nishino T, Kimura T, Kurioka H, Fujimoto S, Dohi K.
    Pathobiology; 1998 Feb; 66(5):221-9. PubMed ID: 9732237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.